To observe the specific therapeutic effect of chronic pelvic inflammatory disease in obstetrics and gynecology
观察慢性盆腔炎妇产科临床治疗过程中的具体治疗效果

摘要

目的 评估结合中西医治疗方法与传统抗生素治疗在慢性盆腔炎患者中的疗效差异。方法 选取2022年至2023年在本院门诊就诊的100例慢性盆腔炎患者，随机分为实验组和对照组。实验组采用中西医结合疗法，对照组仅使用抗生素（甲硝唑片和左氧氟沙星片）。主要观察指标包括红细胞沉降率、hs-CRP水平和临床疗效评定。结果 观察组在红细胞沉降率和hs-CRP水平上的降低比对照组显著，临床疗效也优于对照组。两组不良反应发生率差异显著，实验组较低。结论 中西医结合疗法在治疗慢性盆腔炎方面，相比于传统抗生素治疗，显示出更好的疗效和较低的不良反应发生率。

Abstract

Objective To evaluate the therapeutic effect of combined Chinese and western medicine and traditional antibiotics in patients with chronic pelvic inflammatory disease.
Methods A total of 100 patients with chronic pelvic inflammatory disease in our hospital from 2022 to 2023 were randomly divided into experimental group and control group. The experimental group was treated with integrated Chinese and western medicine, while the control group was treated with antibiotics only (metronidazole tablets and levofloxacin tablets). The main outcome measures included erythrocyte sedimentation rate, hs-CRP level and clinical efficacy evaluation.
Results The erythrocyte sedimentation rate and hs-CRP levels in the observation group were significantly lower than those in the control group, and the clinical efficacy was better than that in the control group. The incidence of adverse reactions was significantly different between the two groups, and the experimental group was lower.
Conclusion   The combination of traditional Chinese and western medicine in the treatment of chronic pelvic inflammatory disease, compared with the traditional antibiotic treatment, shows better efficacy and lower incidence of adverse reactions.